Key facts
- Affinity Asset Advisors, LLC filed SCHEDULE 13G for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA).
- Disclosed ownership: 5.5%.
- Date of event: 25 Nov 2025.
Affinity Asset Advisors, LLC - 25 Nov 2025 SCHEDULE 13G Report for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA)
- Filing Manager
- Affinity Asset Advisors, LLC
- Reporting Manager
- Affinity Asset Advisors, LLC
- Symbol
- VRCA
- Shares outstanding
- 16,164,022 shares
- Disclosed Ownership
- 884,172 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Dec 2025, 15:20:11 UTC
- Date of event
- 25 Nov 2025
- Next filing
- 29 Jan 2026
- SEC
- View on sec.gov
Key filing fact
Affinity Asset Advisors, LLC disclosed 5.5% ownership in Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value per share (VRCA) on 25 Nov 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Dec 2025, 15:20.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 5.5% | 884,172 | 0 | 884,172 | /s/ Andrew Weinstein | Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer | |
| Affinity Healthcare Fund, LP | 5.5% | 884,172 | 0 | 884,172 | /s/ Andrew Weinstein | Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer |
CIK / CUSIP context first